ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Omass Therapeutics Limited

Omass Therapeutics Limited is an active company incorporated on 26 February 2016 with the registered office located in Oxford, Oxfordshire. Omass Therapeutics Limited was registered 9 years ago.
Status
Active
Active since incorporation
Company No
10028228
Private limited company
Age
9 years
Incorporated 26 February 2016
Size
Unreported
Confirmation
Submitted
Dated 12 March 2025 (7 months ago)
Next confirmation dated 12 March 2026
Due by 26 March 2026 (5 months remaining)
Last change occurred 7 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (11 months remaining)
Address
Building 4000 John Smith Drive
Oxford Business Park South
Oxford
OX4 2GX
England
Address changed on 21 Mar 2023 (2 years 7 months ago)
Previous address was Schrödinger Building Heatley Road Oxford Science Park Oxford OX4 4GE England
Telephone
01865309663
Email
Unreported
People
Officers
12
Shareholders
68
Controllers (PSC)
2
Director • British • Lives in England • Born in Feb 1973
Director • British • Lives in England • Born in Feb 1960
Director • Executive Venture Partner • American • Lives in United States • Born in Dec 1955
Director • American • Lives in United States • Born in Aug 1963
Director • British • Lives in UK • Born in Apr 1984
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Syncona Discovery Limited
Magdalena Anna Jonikas is a mutual person.
Active
Resolution Therapeutics Limited
Edward Eliot Hodgkin is a mutual person.
Active
Mosaic Therapeutics Limited
Magdalena Anna Jonikas is a mutual person.
Active
Kesmalea Therapeutics Limited
Magdalena Anna Jonikas is a mutual person.
Active
Azeria Therapeutics Limited
Magdalena Anna Jonikas is a mutual person.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2016–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£49.3M
Increased by £12.06M (+32%)
Turnover
Unreported
Same as previous period
Employees
60
Same as previous period
Total Assets
£59.19M
Increased by £13.99M (+31%)
Total Liabilities
-£4.04M
Increased by £52K (+1%)
Net Assets
£55.14M
Increased by £13.93M (+34%)
Debt Ratio (%)
7%
Decreased by 2% (-23%)
Latest Activity
Full Accounts Submitted
1 Month Ago on 11 Sep 2025
Ms Carol Anne Schafer Appointed
3 Months Ago on 7 Jul 2025
Confirmation Submitted
7 Months Ago on 21 Mar 2025
Dr Birgitte Volck Appointed
8 Months Ago on 1 Feb 2025
Full Accounts Submitted
1 Year 5 Months Ago on 2 May 2024
Confirmation Submitted
1 Year 6 Months Ago on 2 Apr 2024
Small Accounts Submitted
2 Years 4 Months Ago on 5 Jun 2023
Mr James Arthur Geraghty Appointed
2 Years 5 Months Ago on 9 May 2023
Confirmation Submitted
2 Years 6 Months Ago on 3 Apr 2023
Registered Address Changed
2 Years 7 Months Ago on 21 Mar 2023
Get Credit Report
Discover Omass Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Full accounts made up to 31 December 2024
Submitted on 11 Sep 2025
Change of share class name or designation
Submitted on 15 Aug 2025
Appointment of Ms Carol Anne Schafer as a director on 7 July 2025
Submitted on 29 Jul 2025
Appointment of Dr Birgitte Volck as a director on 1 February 2025
Submitted on 8 May 2025
Confirmation statement made on 12 March 2025 with updates
Submitted on 21 Mar 2025
Resolutions
Submitted on 11 Feb 2025
Memorandum and Articles of Association
Submitted on 11 Feb 2025
Change of share class name or designation
Submitted on 10 Jan 2025
Change of share class name or designation
Submitted on 21 Oct 2024
Statement of capital following an allotment of shares on 31 July 2024
Submitted on 7 Aug 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year